1. Home
  2. RPC vs OLMA Comparison

RPC vs OLMA Comparison

Compare RPC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ridgepost Capital Inc. Class A Common Stock

RPC

Ridgepost Capital Inc. Class A Common Stock

N/A

Current Price

$7.50

Market Cap

960.2M

Sector

Finance

ML Signal

N/A

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

N/A

Current Price

$8.23

Market Cap

949.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RPC
OLMA
Founded
1992
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
960.2M
949.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
RPC
OLMA
Price
$7.50
$8.23
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$12.75
★ $36.50
AVG Volume (30 Days)
480.4K
★ 974.3K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
★ 2.15%
N/A
EPS Growth
6.25
★ 15.00
EPS
★ 0.14
N/A
Revenue
★ $297,346,000.00
N/A
Revenue This Year
$20.02
N/A
Revenue Next Year
$16.79
N/A
P/E Ratio
$52.44
★ N/A
Revenue Growth
★ 0.30
N/A
52 Week Low
$6.79
$6.65
52 Week High
$9.51
$36.26

Technical Indicators

Market Signals
Indicator
RPC
OLMA
Relative Strength Index (RSI) 39.95 31.81
Support Level $7.54 N/A
Resistance Level $8.02 $11.27
Average True Range (ATR) 0.23 0.48
MACD -0.03 -0.09
Stochastic Oscillator 39.47 12.94

Price Performance

Historical Comparison
RPC
OLMA

About RPC Ridgepost Capital Inc. Class A Common Stock

Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue mainly comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: